JNJ-5207852

CAS No. 398473-34-2

JNJ-5207852 ( —— )

Catalog No. M20744 CAS No. 398473-34-2

JNJ-5207852 is a novel non-imidazole histamine H3 receptor antagonist with high affinity at the rat (pKi=8.9) and human (pKi=9.24) H3 receptor.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
2MG 40 In Stock
5MG 65 In Stock
10MG 102 In Stock
25MG 215 In Stock
50MG 426 In Stock
100MG 624 In Stock
200MG Get Quote In Stock
500MG Get Quote In Stock
1G Get Quote In Stock

Biological Information

  • Product Name
    JNJ-5207852
  • Note
    Research use only not for human use.
  • Brief Description
    JNJ-5207852 is a novel non-imidazole histamine H3 receptor antagonist with high affinity at the rat (pKi=8.9) and human (pKi=9.24) H3 receptor.
  • Description
    JNJ-5207852 is a novel non-imidazole histamine H3 receptor antagonist with high affinity at the rat (pKi=8.9) and human (pKi=9.24) H3 receptor.
  • Synonyms
    ——
  • Pathway
    GPCR/G Protein
  • Target
    Histamine Receptor
  • Recptor
    H3 receptor
  • Research Area
    ——
  • Indication
    ——

Chemical Information

  • CAS Number
    398473-34-2
  • Formula Weight
    316.48
  • Molecular Formula
    C20H32N2O
  • Purity
    >98% (HPLC)
  • Solubility
    DMSO:77.5 mg/mL (244.88 mM)
  • SMILES
    C(COc1ccc(CN2CCCCC2)cc1)CN1CCCCC1
  • Chemical Name
    ——

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

1.Esbenshade T A Browman K E Bitner R S et al. The histamine H3 receptor: an attractive target for the treatment of cognitive disorders[J]. 2008 154(6):1166-1181.
molnova catalog
related products
  • Diphenhydramine hydr...

    Diphenhydramine HCl (Benadryl), a histamine H1 antagonist used as an antiemetic, antitussive.

  • Ebrotidine

    Ebrotidine is a competitive H2-receptor antagonist with Ki of 127.5 nM. Ebrotidine has a potent antisecretory activity and evidenced gastroprotection.

  • Betahistine dihydroc...

    Betahistine Dihydrochloride is a histamine H3 receptors inhibitor used as an antivertigo drug.